HomeNews News Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unit Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unit

Read more interesting news from around the globe with Wealth Doctor App

Google Play
 
Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unit

Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unit

Tuesday, March 14, 2017, 2:46 PM

Shares of Sun Pharmaceuticals shot up nearly 7% in Tuesday’s trade after it said that the USFDA has lifted the import alert imposed on the company’s Mohali manufacturing facility and remove the facility from the Official Action Initiated (OAI) status. This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Love Beyond Death Get It now!